A Medical Education Documentary

A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story

Are you able to diagnose Alpha-1 Antitrypsin Deficiency in your patients? AATD is often misdiagnosed, resulting in patients experiencing years of delayed accurate diagnosis. Watch this documentary and hear from leading clinicians and patients on their experiences.

CME/CE Credit


CME/CE Information

Activity Title A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
Topic AATD
Accreditation Type AMA PRA Category 1 Credits
Release Date December 13, 2018
Expiration Date December 12, 2019
Estimated Time to Complete Activity 30 minutes


Upon completion of the activity, participants should be able to:

  • Identify strategies that support early/accurate recognition and treatment of AATD


Robert A. Sandhaus, MD, PhD
Professor of Medicine
Director, Alpha-1 Program
National Jewish Health
Denver, Colorado

Karina Serban, MD
Assistant Professor of Medicine
Department of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
National Jewish Health
Denver, Colorado


  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity.
  4. Complete the online posttest. A score of 100% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Credit documentation/reporting: If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation, your CME/CE certificate will be available for download.



This activity is provided by The France Foundation.


This activity is intended for pulmonologists, critical care specialists, and other health care providers involved in the management of patients with pulmonary disease.


Alpha-1 antitrypsin deficiency (AATD) is a common hereditary disorder that puts patients at risk for chronic obstructive pulmonary disease (COPD) with early-onset emphysema. Unfortunately, this disorder is widely understood to be under recognized and the consequences of a missed or delayed diagnosis can be severe. Up to 90% of patients with AATD are misdiagnosed, based on symptoms similar to non-deficiency COPD, or asthma.


The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.


In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty report that they have relevant financial relationships to disclose:

  • Robert A. Sandhaus, MD, PhD, has served as consultant for AstraZeneca, CSL Behring, Grifols, InhibRx and Mereo.

The following faculty report that they have no relevant financial relationships to disclose:

  • Karina Serban, MD


TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc. and Grifols.


The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.


Copyright © 2018 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.


If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or This email address is being protected from spambots. You need JavaScript enabled to view it..